Le Lézard
Classified in: Science and technology
Subjects: Product/Service, Survey

Origami Risk Launches Package of Generative AI Solutions for Risk Managers


Origami Risk, the industry-leading risk, safety, and insurance Software as a Service (SaaS) technology firm, will launch its new package of Generative AI (GenAI) solutions for risk managers at RIMS in San Diego next week as it urges risk managers to take an informed approach to adopting and integrating the latest artificial intelligence tools.

In response to the acceleration of GenAI, Origami is launching two prototypes that aim to safely guide risk and insurance professionals through the strategic adoption of AI. It has also introduced a GenAI Product Pilot Program, which enables a selection of Origami's clients to help shape the development of Origami's own AI features.

Origami has developed AI Risk Identifier to support risk managers in the planning phase of their AI journey. AI Risk Identifier assesses potential AI use cases (both in progress or pre-development) to identify and mitigate the risks involved. It will also determine the risks and opportunities associated with different potential use cases so risk managers can strategically prioritize their activities and mitigate the risks associated with them.

Origami's GenAI Pilot Program has gathered several of the firm's clients to pilot potential future use cases for the business. These include the ability to review audit responses and use Open AI to recommend potential corrective action for low-scoring areas. It also features technology to quickly summarize claims and compose task lists and emails.

Audit Accelerator has been developed in partnership with Origami's subsidiary Dais. The technology runs safety audits at scale, without a human bottleneck, wherever there is a live camera. From a simple photo upload, businesses will increase their efficiency by potentially removing the need for people to perform physical safety audits across multiple sites in multiple locations. A visual dashboard allows clients to see a basic comparison of claims frequency and severity based on both before, and after Audit Accelerator was implemented. All of these initiatives will be integrated into Origami's single platform, making it simple for risk professionals to access and utilize these tools within a secure, cloud-based environment,

In its upcoming ?State of Risk' report, which surveys the attitudes and opinions of 240 risk professionals across Europe and North America, Origami found that although 1 in 4 do not rank GenAI as a priority for their organization, over a third of responders are actively in discussion or planning phase.

Earne Bentley, President of Risk Solutions, Origami Risk remarked: "The risks associated with AI are very real and rapidly evolving. But the risks, in the form of lost opportunities, are even greater in the long run for organizations that do not move forward with well-governed, AI-enabled processes. Our State of Risk report highlights that although few risk professionals rate GenAI as a priority for their business, many are working on its applications anyway. We're concerned that in the rush to embrace the possibilities of this evolving technology, many professionals may abandon best practices and create bigger problems for their organizations in the long run."

He continued: "Our package of GenAI solutions represents a safe, strategic and purposeful approach to these technologies that will help risk managers to safely explore and adopt GenAI in a robust and sustainable manner."

This news follows the announcement of AI-driven claims optimization capabilities thanks to Origami's partnership with CLARA Analytics. The partnership gives Origami's clients access to tried and trusted machine learning, predictive AI, natural language processing (NLP), and generative AI (GenAI) to increase claims efficiency.

About Origami Risk
Origami Risk provides truly integrated SaaS solutions that simplify risk, insurance, compliance, and safety management. Origami delivers its highly configurable RMIS, GRC, EHS, and healthcare risk management solutions from a secure, scalable platform that includes tools for centralizing data, automating critical workflows, and providing insights into risk and safety initiatives. A singular focus on client success underlies Origami's approach to developing, implementing, and supporting their innovative, award-winning software. Visit origamirisk.com or contact us at [email protected] to learn more.


These press releases may also interest you

at 08:20
Intercontinental Exchange, Inc. ("ICE") announced today that as of 5:00 p.m., New York City time, on May 16, 2024 (the "Early Tender Deadline"), $997.4 million in aggregate principal amount of outstanding 3.625% Senior Notes due 2028 (CUSIP:...

at 08:10
Guardant Health, Inc. , a leading precision oncology company, today announced that on April 22, 2024, the Compensation Committee of Guardant's Board of Directors approved the granting of restricted stock units ("RSUs") representing 215,601 shares of...

at 08:08
Victoria Eye Center/Victoria Surgery Center/Victoria Vision Center ("VEC") is writing to provide information regarding an event that involves certain information relating to personal health information.  On March 21, 2024, VEC became aware that...

at 08:05
CCC Intelligent Solutions Holdings Inc. (CCC) , a leading cloud platform powering the P&C insurance economy, today announced that management will present at the following investor conferences: The J.P. Morgan Global Technology, Media and...

at 08:05
Azitra, Inc. , a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today announced preclinical data from the Company's platform and pipeline. The data are being presented on Friday, May 17,...

at 08:05
Immunome, Inc. , a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced the promotion of Max Rosett to Chief Financial Officer, effective May 9. Mr. Rosett most recently held the role...



News published on and distributed by: